Literature DB >> 2846780

Subcellular distribution studies of diadenosine polyphosphates--Ap4A and Ap5A--in bovine adrenal medulla: presence in chromaffin granules.

A Rodriguez del Castillo1, M Torres, E G Delicado, M T Miras-Portugal.   

Abstract

Diadenosine tetraphosphate (Ap4A) and diadenosine pentaphosphate (Ap5A) have been identified in bovine adrenal medullary tissue using an HPLC method. The values obtained were 0.1 +/- 0.05 mumol/g of tissue for both compounds. The subcellular fraction where Ap4A and Ap5A were present in the highest concentration was chromaffin granules: 32 nmol/mg of protein for both compounds (approximately 6 mM intragranularly). This value was 30 times higher than in the cytosolic fraction. Enzymatic degradation of Ap4A and Ap5A, isolated from chromaffin granules, with phosphodiesterase produces AMP as the final product. The Ap4A and Ap5A obtained from this tissue were potent inhibitors of adenosine kinase. Their Ki values relative to adenosine were 0.3 and 2 microM for Ap4A and Ap5A, respectively. The cytosolic fraction also contains enzymatic activities that degrade Ap4A as well as Ap5A. These activities were measured by an HPLC method; the observed Km values were 10.5 +/- 0.5 and 13 +/- 1 microM for Ap4A and Ap5A, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846780     DOI: 10.1111/j.1471-4159.1988.tb01147.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

1.  Ca(2+)-stores mobilization by diadenosine tetraphosphate, Ap4A, through a putative P2Y purinoceptor in adrenal chromaffin cells.

Authors:  E Castro; J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.

Authors:  J Mateo; M T Miras-Portugal; E Castro
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 3.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  Diadenosine polyphosphate hydrolase from presynaptic plasma membranes of Torpedo electric organ.

Authors:  J Mateo; P Rotllan; E Marti; I Gomez De Aranda; C Solsona; M T Miras-Portugal
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 5.  Dinucleoside polyphosphates and their interaction with other nucleotide signaling pathways.

Authors:  Esmerilda G Delicado; M Teresa Miras-Portugal; Luz María G Carrasquero; David León; Raquel Pérez-Sen; Javier Gualix
Journal:  Pflugers Arch       Date:  2006-05-11       Impact factor: 3.657

6.  Effects of diadenosine polyphosphates, ATP and angiotensin II on membrane voltage and membrane conductances of rat mesangial cells.

Authors:  R Kleta; J Hirsch; S Heidenreich; H Schlüter; W Zidek; E Schlatter
Journal:  Pflugers Arch       Date:  1995-09       Impact factor: 3.657

7.  Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.

Authors:  J Pintor; M A Díaz-Rey; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.

Authors:  C H Hoyle; A U Ziganshin; J Pintor; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Acyl coenzyme A synthetase from Pseudomonas fragi catalyzes the synthesis of adenosine 5'-polyphosphates and dinucleoside polyphosphates.

Authors:  R Fontes; M A Sillero; A Sillero
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

10.  Effects of PPADS and suramin on contractions and cytoplasmic Ca2+ changes evoked by AP4A, ATP and alpha, beta-methylene ATP in guinea-pig urinary bladder.

Authors:  S Usune; T Katsuragi; T Furukawa
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.